Pfizer sees emergency use filing for Covid-19 vaccine after US election
The regulatory filing for the vaccine could come as soon as safety data is available in the third week of November, Pfizer said, lifting the company’s shares and the broader U.S. stock market.
No hay comentarios:
Publicar un comentario